MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 30 filers reported holding MERUS N V in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,000 | – | 3,131 | +31210.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 10 | -87.5% | 0.00% | – |
| Q1 2023 | $1,000 | 0.0% | 80 | -4.8% | 0.00% | – |
| Q4 2022 | $1,000 | – | 84 | +600.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 12 | -98.5% | 0.00% | – |
| Q1 2021 | $17,000 | +325.0% | 818 | +172.7% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -14.3% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 300 | +14900.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
| COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
| MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
| Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
| BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
| TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
| Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |